ANAB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - AnaptysBio Inc

Watchlist Manager

Watchlist

Price: 51.63 USD 0.53% Market Closed

Market Cap: $1.5B

	AnaptysBio Inc NASDAQ:ANAB	US
	Beneteau SA F:3GD	FR
R	Rigel Pharmaceuticals Inc F:RI2A	US
A	Angi Inc F:2UH	US
A	Autozone Inc XBER:AZ5	US
A	Accuray Inc SWB:XEJ	US
T	thyssenkrupp AG DUS:TKA	DE
	US Gold Corp NASDAQ:USAU	US
	Buckle Inc NYSE:BKE	US
R	ReproCell Inc F:6RC	JP
	Bank Syariah Indonesia Tbk PT IDX:BRIS	ID
	Ajinomoto Co Inc TSE:2802	JP
P	PetroChina Co Ltd XBER:PC6	CN
N	Nov Inc XBER:NO8	US

Profitability Summary

AnaptysBio Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Healthy Operating Margin

20%

Negative 3Y Average Operating Margin

-434%

Operating Margin is Increasing

-1 196% > 20%

Negative Net Margin

-6%

Negative 3Y Average Net Margin

-460%

Net Margin is Increasing

-1 279% > -6%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-327%

Free Cash Flow Margin is Increasing

-726% > 8%

Negative ROE

-24%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-130%

ROIC is Increasing

-109% > 68%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.